Trials
Search / Trial NCT05653492

Safety, Feasibility, and Tolerability of Sulforaphane in Children with Chronic Kidney Disease

Launched by UNIVERSITY OF ROCHESTER · Dec 7, 2022

Trial Information

Current as of January 22, 2025

Active, not recruiting

Keywords

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • diagnosis of chronic of kidney disease
  • have eGFR 20-59 mL/min/1.73m2 at the time of enrollment
  • parents must be able to provide consent
  • Exclusion Criteria:
  • weight \<30 kg
  • cancer or HIV diagnosis
  • history of solid organ transplantation (including kidney transplant)
  • structural heart disease
  • currently pregnant or plan to become pregnant
  • life expectancy is less than one year
  • Patients will also be excluded if they are currently taking anticoagulants, immunosuppression, or chemotherapeutics

About University Of Rochester

The University of Rochester is a leading academic institution dedicated to advancing medical research and improving patient care through innovative clinical trials. Renowned for its commitment to excellence in education, research, and clinical practice, the university fosters a collaborative environment that integrates cutting-edge scientific inquiry with practical applications in healthcare. With a focus on diverse therapeutic areas, the University of Rochester aims to enhance treatment options and outcomes for patients while contributing to the broader scientific community through rigorous study design and ethical standards in clinical research.

Locations

Rochester, New York, United States

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0

Similar Trials